Iroxanadine is a MAPK p38 inhibitor potentially for the treatment of atherosclerosis. References: Denes L, Bori Z, Csonka E, Entz L, Nagy Z. Reverse regulation of endothelial cells and myointimal hyperplasia on cell proliferation by a heatshock protein-coinducer after hypoxia. Stroke. 2008 Mar;39(3):1022-4. doi: 10.1161/STROKEAHA.107.495754. PubMed PMID: 18239173.

纯度：≥98%

CAS：276690-58-5